83027-0124 NDC - BONE LIQUESCENCE (TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, CALCAREA MURIATICA, EQUISETUM ARVENSE, JUGLANS NIGRA, SESAME OIL, CALCAREA SULPHURICA, HEPAR (BOVINE), KIDNEY (BOVINE), MEDULLA OSSIS SUIS, MENADIONE, THYROIDINUM (BOVINE), VITAMIN A, VITAMIN D3, CALCAREA PHOSPHORICA, CALCAREA CARBONICA, CALCAREA FLUORICA, MANGANUM METALLICUM, NICCOLUM METALLICUM, MAGNESIUM METALLICUM)

Drug Information

Product NDC: 83027-0124

Proprietary Name: Bone Liquescence

Non Proprietary Name: Taraxacum Officinale, Trifolium Pratense, Calcarea Muriatica, Equisetum Arvense, Juglans Nigra, Sesame Oil, Calcarea Sulphurica, Hepar (Bovine), Kidney (Bovine), Medulla Ossis Suis, Menadione, Thyroidinum (Bovine), Vitamin A, Vitamin D3, Calcarea Phosphorica, Calcarea Carbonica, Calcarea Fluorica, Manganum Metallicum, Niccolum Metallicum, Magnesium Metallicum

Active Ingredient(s):
  • 6 [hp_X]/mL BEEF KIDNEY;
  • 4 [hp_X]/mL BLACK WALNUT HUSK;
  • 4 [hp_X]/mL CALCIUM CHLORIDE;
  • 12 [hp_X]/mL CALCIUM FLUORIDE;
  • 5 [hp_X]/mL CALCIUM SULFATE ANHYDROUS;
  • 6 [hp_X]/mL CHOLECALCIFEROL;
  • 4 [hp_X]/mL EQUISETUM ARVENSE TOP;
  • 6 [hp_X]/mL HEPARIN, BOVINE;
  • 15 [hp_X]/mL MAGNESIUM;
  • 12 [hp_X]/mL MANGANESE;
  • 6 [hp_X]/mL MENADIONE;
  • 12 [hp_X]/mL NICKEL;
  • 9 [hp_X]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE;
  • 4 [hp_X]/mL SESAME OIL;
  • 6 [hp_X]/mL SUS SCROFA BONE MARROW;
  • 3 [hp_X]/mL TARAXACUM OFFICINALE;
  • 6 [hp_X]/mL THYROID, BOVINE;
  • 9 [hp_X]/mL TRIBASIC CALCIUM PHOSPHATE;
  • 3 [hp_X]/mL TRIFOLIUM PRATENSE FLOWER;
  • 6 [hp_X]/mL VITAMIN A


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Allergens [CS];
  • Blood Coagulation Factor [EPC];
  • Blood Coagulation Factor [EPC];
  • Blood Coagulation Factor [EPC];
  • Calcium [CS];
  • Calcium [CS];
  • Calcium [CS];
  • Cations;
  • Divalent [CS];
  • Cations;
  • Divalent [CS];
  • Cations;
  • Divalent [CS];
  • Cell-mediated Immunity [PE];
  • Increased Coagulation Factor Activity [PE];
  • Increased Coagulation Factor Activity [PE];
  • Increased Coagulation Factor Activity [PE];
  • Increased Histamine Release [PE];
  • Phosphate Binder [EPC];
  • Phosphate Binder [EPC];
  • Phosphate Binder [EPC];
  • Phosphate Chelating Activity [MoA];
  • Phosphate Chelating Activity [MoA];
  • Phosphate Chelating Activity [MoA];
  • Standardized Chemical Allergen [EPC];
  • Vitamin A [CS];
  • Vitamin A [EPC];
  • Vitamin D [CS];
  • Vitamin D [EPC]

Labeler Information

Labeler Name: Nutritional Specialties, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:11/17/2023

Package Information

No. Package Code Package Description Billing Unit
183027-0124-1120 mL in 1 BOTTLE, DROPPER (83027-0124-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC83027-0124The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEBone LiquescenceThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMETaraxacum Officinale, Trifolium Pratense, Calcarea Muriatica, Equisetum Arvense, Juglans Nigra, Sesame Oil, Calcarea Sulphurica, Hepar (Bovine), Kidney (Bovine), Medulla Ossis Suis, Menadione, Thyroidinum (Bovine), Vitamin A, Vitamin D3, Calcarea Phosphorica, Calcarea Carbonica, Calcarea Fluorica, Manganum Metallicum, Niccolum Metallicum, Magnesium MetallicumThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE11/17/2023This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENutritional Specialties, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEBEEF KIDNEY; BLACK WALNUT HUSK; CALCIUM CHLORIDE; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; CHOLECALCIFEROL; EQUISETUM ARVENSE TOP; HEPARIN, BOVINE; MAGNESIUM; MANGANESE; MENADIONE; NICKEL; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SESAME OIL; SUS SCROFA BONE MARROW; TARAXACUM OFFICINALE; THYROID, BOVINE; TRIBASIC CALCIUM PHOSPHATE; TRIFOLIUM PRATENSE FLOWER; VITAMIN AAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 4; 4; 12; 5; 6; 4; 6; 15; 12; 6; 12; 9; 4; 6; 3; 6; 9; 3; 6 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Standardized Chemical Allergen [EPC], Vitamin A [CS], Vitamin A [EPC], Vitamin D [CS], Vitamin D [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 4/12/2024